Bob Gasparini is a longtime leader in clinical laboratory science and molecular diagnostics, with a distinguished career spanning scientific research, laboratory management, and executive leadership. He retired in 2021 after 17 years at NeoGenomics, where he served as President, Chief Science Officer, and a member of the Board of Directors. Earlier in his career, he held senior roles including Director of the Genetics Division at US Labs, Molecular Marketing Manager at Ventana Medical Systems, and Assistant Director of the Cytogenetics Laboratory for the Prenatal Diagnostic Center affiliated with Massachusetts General Hospital. He has served on the Board of Directors of Klinkhart Hall Arts Center since 2023 and has contributed in multiple committee roles.